Bli medlem
Bli medlem

Du är här

2015-04-21

Bellevue Group AG: Bellevue Asset Management successfully concludes integration of Adamant Biomedical Investments

Bellevue Group AG / Bellevue Asset Management successfully concludes
integration of AdamantBiomedical Investments . Processed and transmitted by
NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the
content of this announcement.
* Integration of Adamant Biomedical Investments completed as planned on April
21, 2015; merger of Adamant Biomedical Investments and Bellevue Asset
Management approved by FINMA
* Transfer of Adamant's investment fund product range, investment mandates
and assets under management of CHF 831 million to Bellevue Asset Management

* Total assets under management at Bellevue Asset Management now amount to
more than CHF 5.5 billion

Having received regulatory approval from FINMA on April 16, 2015, Bellevue
Asset Management AG has merged with Adamant Biomedical Investments AG
(Adamant), which was acquired from Zürcher Kantonalbank in September 2014,
with effect from April 21, 2015. Upon consummation of the merger, Adamant's
investment funds and mandates business with assets of CHF 831 million under
management have been transferred to Bellevue Asset Management. This
transaction strengthens Bellevue Asset Management's healthcare investment
capabilities and product offering in both qualitative and quantitative terms
and its leading international position in this business. Bellevue Asset
Management now has assets under management of more than CHF 5.5 billion (as
of March 31, 2015).

The nine-strong team headed by Dr. Cyrill Zimmermann will additionally assume
management responsibility for Bellevue Asset Management's investment fund and
mandates business in the healthcare segment. The well-known Adamant brand
will be retained at the product level. BB Biotech AG, the flagship product at
Bellevue Asset Management, will remain under the management and guidance of
the proven team of professionals headed by Dr. Daniel Koller.

"The completion of the merger with Adamant represents another milestone in the
corporate development of Bellevue Asset Management and creates interesting
growth opportunities, both national and international. At the same time our
clients benefit from our enhanced investment competence and a larger product
range. Thanks to the very good collaboration with our new colleagues we were
able to close the acquisition with this integration both smoothly and
swiftly," comments André Rüegg, CEO Bellevue Asset Management.

Contacts:

Media Relations:

André Rüegg, CEO Bellevue Asset Management

Telephone +41 44 267 67 00, Fax +41 44 267 67 01, aru@bellevue.ch

Investor Relations:

Daniel Koller, CFO Bellevue Group

Telephone +41 44 267 67 00, Fax +41 44 267 67 01, ir@bellevue.ch

Bellevue Group

Bellevue Group is an independent Swiss financial boutique listed on the SIX
Swiss Exchange. Established in 1993, the company and its approximately 90
employees are specialists in the fields of Brokerage, Corporate Finance and
Asset Management. Bellevue Group includes the two subsidiaries Bank am
Bellevue and Bellevue Asset Management. The bank boasts strong knowledge of
the Swiss stock and bond market and offers independent research opinions and
recommendations as well as viable solutions for capital market transactions.
Bellevue Asset Management is focused on selected active equity investment
strategies in growing markets, in healthcare industries as well as in other
special themes such as entrepreneur-led companies.

Press Release (PDF)
http://hugin.info/137269/R/1913028/683067.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bellevue Group AG via Globenewswire

HUG#1913028

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.